Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.01
Jun. 03, 2025 12:24:18- Change 0.082 (8.83621%)
- Volume 121,809
- Today's Open 0.92
- Previous Close 0.928
- Today's High 1.01
- Today's Low 0.95
- 52 Week High 4.3
- 52 Week Low 0.9099